• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Gene Editing Companies

    ID: MRFR/LS/0236-CR
    128 Pages
    Rahul Gotadki
    June 2024

    Gene editing technology, dedicated to revolutionizing the future of healthcare and biotechnology. Our mission is to empower researchers, clinicians, and industries with cutting-edge tools that allow precise manipulation of genetic material for therapeutic, agricultural, and research purposes.

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Top Industry Leaders in the Gene Editing Market

    Gene Editing Key Companies

     

    Latest Gene Editing Companies Update


    Caribou Biosciences (US) Announced a collaboration with the Broad Institute of MIT and Harvard to develop new gene editing tools for cancer immunotherapy.


    Veritas AG Received CE Mark approval for its gene editing kit for research applications, marking a significant step towards wider accessibility of the technology.


    Beam Therapeutics Entered into a licensing agreement with Boehringer Ingelheim (Germany) to develop gene therapies for liver diseases, expanding their therapeutic reach.


    Synthego Launched a new service offering for custom CRISPR guide RNA design and synthesis, cateriing to the growing demand for research tools.


    List of Gene Editing Key Companies in the Market



    • GE Healthcare (US)

    • Thermo Fisher Scientific Inc (US)

    • Bio-Rad Laboratories, Inc (US)

    • Lonza (Switzerland)

    • GenScript (US)

    • Horizon Discovery Ltd (UK)

    • OriGene Technologies, Inc (US)

    • Integrated DNA Technologies, Inc (US)

    • New England Biolabs, Inc (US)

    • Sangamo Therapeutics (US)